Global Neoantigen Targeted Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 221387
  • calendar_today Published On: Dec, 2019
  • file_copy Pages: 107
  • list Medical Devices

Description

Scope of the Report:

The global Neoantigen Targeted Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neoantigen Targeted Therapies.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Neoantigen Targeted Therapies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neoantigen Targeted Therapies market by product type and applications/end industries.

Market Segment by Companies, this report covers

Bavarian Nordic

Neon Therapeutics

Immunicum

Genocea Biosciences

MediGene

Gradalis

Iovance Biotherapeutics

Immunovative Therapies

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monotherapy

Combination Therapy

Market Segment by Applications, can be divided into

Medical Research Institution

Hospital and Clinic

Other

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Neoantigen Targeted Therapies Market Overview

1.1 Product Overview and Scope of Neoantigen Targeted Therapies

1.2 Classification of Neoantigen Targeted Therapies by Types

1.2.1 Global Neoantigen Targeted Therapies Revenue Comparison by Types (2019-2024)

1.2.2 Global Neoantigen Targeted Therapies Revenue Market Share by Types in 2018

1.2.3 Monotherapy

1.2.4 Combination Therapy

1.3 Global Neoantigen Targeted Therapies Market by Application

1.3.1 Global Neoantigen Targeted Therapies Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Medical Research Institution

1.3.3 Hospital and Clinic

1.3.4 Other

1.4 Global Neoantigen Targeted Therapies Market by Regions

1.4.1 Global Neoantigen Targeted Therapies Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.5 Global Market Size of Neoantigen Targeted Therapies (2014-2024)

2 Company Profiles

2.1 Bavarian Nordic

2.1.1 Business Overview

2.1.2 Neoantigen Targeted Therapies Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Bavarian Nordic Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.2 Neon Therapeutics

2.2.1 Business Overview

2.2.2 Neoantigen Targeted Therapies Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Neon Therapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.3 Immunicum

2.3.1 Business Overview

2.3.2 Neoantigen Targeted Therapies Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Immunicum Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.4 Genocea Biosciences

2.4.1 Business Overview

2.4.2 Neoantigen Targeted Therapies Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Genocea Biosciences Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.5 MediGene

2.5.1 Business Overview

2.5.2 Neoantigen Targeted Therapies Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 MediGene Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.6 Gradalis

2.6.1 Business Overview

2.6.2 Neoantigen Targeted Therapies Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Gradalis Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.7 Iovance Biotherapeutics

2.7.1 Business Overview

2.7.2 Neoantigen Targeted Therapies Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.8 Immunovative Therapies

2.8.1 Business Overview

2.8.2 Neoantigen Targeted Therapies Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Immunovative Therapies Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

3 Global Neoantigen Targeted Therapies Market Competition, by Players

3.1 Global Neoantigen Targeted Therapies Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Neoantigen Targeted Therapies Players Market Share

3.2.2 Top 10 Neoantigen Targeted Therapies Players Market Share

3.3 Market Competition Trend

4 Global Neoantigen Targeted Therapies Market Size by Regions

4.1 Global Neoantigen Targeted Therapies Revenue and Market Share by Regions

4.2 North America Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

4.3 Europe Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

4.5 South America Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

5 North America Neoantigen Targeted Therapies Revenue by Countries

5.1 North America Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

5.2 USA Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

5.3 Canada Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

5.4 Mexico Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6 Europe Neoantigen Targeted Therapies Revenue by Countries

6.1 Europe Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

6.2 Germany Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6.3 UK Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6.4 France Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6.5 Russia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6.6 Italy Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Neoantigen Targeted Therapies Revenue by Countries

7.1 Asia-Pacific Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

7.2 China Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7.3 Japan Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7.4 Korea Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7.5 India Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

8 South America Neoantigen Targeted Therapies Revenue by Countries

8.1 South America Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

8.2 Brazil Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

8.3 Argentina Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

8.4 Colombia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Neoantigen Targeted Therapies by Countries

9.1 Middle East and Africa Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

9.2 Saudi Arabia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9.3 UAE Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9.4 Egypt Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9.5 Nigeria Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9.6 South Africa Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

10 Global Neoantigen Targeted Therapies Market Segment by Type

10.1 Global Neoantigen Targeted Therapies Revenue and Market Share by Type (2014-2019)

10.2 Global Neoantigen Targeted Therapies Market Forecast by Type (2019-2024)

10.3 Monotherapy Revenue Growth Rate (2014-2024)

10.4 Combination Therapy Revenue Growth Rate (2014-2024)

11 Global Neoantigen Targeted Therapies Market Segment by Application

11.1 Global Neoantigen Targeted Therapies Revenue Market Share by Application (2014-2019)

11.2 Neoantigen Targeted Therapies Market Forecast by Application (2019-2024)

11.3 Medical Research Institution Revenue Growth (2014-2019)

11.4 Hospital and Clinic Revenue Growth (2014-2019)

11.5 Other Revenue Growth (2014-2019)

12 Global Neoantigen Targeted Therapies Market Size Forecast (2019-2024)

12.1 Global Neoantigen Targeted Therapies Market Size Forecast (2019-2024)

12.2 Global Neoantigen Targeted Therapies Market Forecast by Regions (2019-2024)

12.3 North America Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

12.4 Europe Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

12.6 South America Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Neoantigen Targeted Therapies Picture

Table Product Specifications of Neoantigen Targeted Therapies

Table Global Neoantigen Targeted Therapies and Revenue (Million U

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery